Is GBT a buy or a sell?
The Discounted Cash Flow (DCF) valuation of Global Blood Therapeutics Inc (GBT) is (548.96) USD. With the latest stock price at 68.49 USD, the upside of Global Blood Therapeutics Inc based on DCF is -901.5%. This means that GBT is a sell according to the DCF valuation model.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.6% - 8.5% | 7.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (1,202.25) - (363.11) | (548.96) |
| Upside | -1855.4% - -630.2% | -901.5% |